| Financial Year |
March 31 2023 |
| Monetary Funds |
19,239,400,388.15 |
| Held-for-trading Financial Assets |
5,945,830,360.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
143,012,357.73 |
| Advances to Suppliers |
16,947,327.61 |
| Other Receivables |
10,109,094.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,058,585,438.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
65,879,704.20 |
| Total Current Assets |
27,479,764,670.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,040,355.53 |
| Fixed Assetes |
4,183,108,363.68 |
| Under-construction Projects |
1,275,134,712.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
762,354,682.32 |
| R&D expenses |
-- |
| Goodwill |
210,428,426.24 |
| Long-Term Deferred and Prepaid Expenses |
9,640,953.01 |
| Deferred Income Tax Assets |
578,201,953.03 |
| Other Non-Current Assets |
15,651,601.17 |
| Sub-Total of Non-Current Assets |
7,078,278,159.63 |
| Total Assets |
34,558,042,829.94 |
| Short-Term Loans |
121,699,908.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,081,010,627.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
503,065,308.05 |
| Taxes Payable |
386,027,287.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,039,333,311.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,062,277.89 |
| Other Current Liabilities |
76,260,417.21 |
| Sub-Total of Current Liabilities |
5,474,337,606.84 |
| Long-term Loans |
119,137,942.28 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,882,860.21 |
| Other Non-Current Liabilities |
19,000,000.00 |
| Sub-Total of Non-Current Liabilities |
475,535,926.49 |
| Total Liabilities |
5,949,873,533.33 |
| Paid-In Capital(Or Share Stock) |
4,633,833,787.00 |
| Capital Surplus |
142,498,802.39 |
| Surplus Reserve |
2,335,492,509.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
21,001,419,196.49 |
| Minority Stockholder's Interest |
494,925,001.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
28,113,244,295.28 |
| Owner's Equity（Stockholder's Equity） |
28,608,169,296.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,558,042,829.94 |
